Skip to main content

Animations

MJFF Publications

1461 - 1470 of 8571 Results
Title
Year
  • Year
  • 2019
  • 2023
  • 2023
  • 2024
  • 2020
  • 2021
  • 2004
  • 2022
  • 2025
  • 2021
  • Summary Details
    OPEN
    Title: Parkinson’s progression prediction using machine learning and serum cytokines
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0086-4
    Citation Count: 98
  • Summary Details
    RESTRICTED
    Title: International Genetic Testing and Counseling Practices for Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29442
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00109-6
    Citation Count: 440
  • Summary Details
    RESTRICTED
    Title: Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awae222
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: ATP13A3 is a major component of the enigmatic mammalian polyamine transport system
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.ra120.013908
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-26066-5
    Citation Count: 164
  • Summary Details
    OPEN
    Title: BAG5 Inhibits Parkin and Enhances Dopaminergic Neuron Degeneration
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2004.11.026
    Citation Count: 196
  • Summary Details
    OPEN
    Title: Holocue: A Wearable Holographic Cueing Application for Alleviating Freezing of Gait in Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.628388
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Diffusion tensor subspace imaging of double diffusion–encoded MRI delineates small fibers and gray‐matter microstructure not visible with single encoding techniques
    Journal Name: Magnetic Resonance in Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mrm.30463
    Citation Count: 0
  • Summary Details
    OPEN
    Title: CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awab103
    Citation Count: 226
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.